Elektron Technology Ophthalmic
Follow Elektron Technology on Twitter  Follow Elektron Technology on Linkedin

MPS II macular pigment screener. Early detection of patients with low macularpigment and at risk of age-related macular degeneration

The Macular Pigment Screener (MPS ll)

Macular pigment screenerThe Macular Pigment Screener (MPS ll) from Elektron Technology is a portable screening device enabling early detection of patients at risk of Age-Related Macular Degeneration (AMD) – the leading cause of vision loss in people over 50.

MPS II white paperFree whitepaper

The use of MPS ll as part of a Macular Screening programme

The paper suggests and outlines pragmatic guidelines for a coherent strategy around Prevention and Management of AMD.

Download the White Paper

In 2011 as many as 11 million Americans had some form of macular degeneration, including both early and later stages of the wet and dry forms3. As the world population ages the number of people affected by AMD is expected to double within 20 years, creating a ‘Silver Tsunami’. This requires a preventative management strategy given that there is no cure for AMD.

Low levels of MP are a modifiable risk factor for AMD1 and once detected, need managing through diet, supplementation and lifestyle in order to minimise the risk of early onset AMD2.

Visual Health: Detect and Protect

The Global cost of AMD was $343 billion dollars in 2010 including US$255 billion direct health care costs.4

Early detection of patients at risk of blindness (AMD)

✓ Empowers proactive care management
✓ Cuts healthcare costs

The world’s first fully portable macular screener

✓ Low cost
✓ Compact
✓ Accurate
✓ Fast, reliable results
✓ CE and FDA approved

1Beatty et al. (1999, 2000, 2001) and Hammond et al. (1998).
2Seddon et all, (1994) JAMA: 272(18), Stringham and Hammond. Optom Vis Sci 85, Richer et al Optometry, Vol 82, No 11




For more information about our Ophthalmic range of products
please contact us at info@elektron-healthcare.com or fill in our enquiry form.